A recently published Joint Consensus Statement from the American Urology Association and the Society of Abdominal Radiology supports that MRI of the prostate plays a key role in prostate cancer detection following an initial negative biopsy. When high quality Prostate MRI is available and further biopsies are recommended prostate MRI and subsequent MRI targeted cores should be strongly considered to detect clinically significant disease over standardised repeat biopsy. To read the full statement. https://www.auanet.org/common/pdf/education/clinical-guidance/Consensus-Statement-Prostate-MRI-and-MRI-Targeted-Biopsy.pdf